Medicine
Volume 36, Issue 8 , Pages 405-409 , August 2008

Schizophrenia

References 

  1. Laruelle M, Abi-Dargham A, van Dyck CH, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A. 1996;93:9235–9240
  2. Abi-Dargham A, Mawlawi O, Lombardo I, et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci. 2002;22:3708–3719
  3. Patil ST, Zhang L, Martenyi F, et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med. 2007;13:1102–1107
  4. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10:40–68
  5. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol. 2005;19:187–194
  6. Spauwen J, Van Os J. The psychosis proneness: psychosis persistence model as an explanation for the association between urbanicity and psychosis. Epidemiol Psichiatr Soc. 2006;15:252–257
  7. Cantor-Graae E. The contribution of social factors to the development of schizophrenia: a review of recent findings. Can J Psychiatry. 2007;52:277–286
  8. Lieberman J, Stroup TS, McEvoy J, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209–1223
  9. McEvoy JP, Lieberman JA, Stroup TS, et al., for the CATIE Investigators  Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006;163:600–610http://www.nimh.nih.gov/health/trials/practical/catie/index.shtmlAvailable from:
  10. Jones PB, Barnes TRE, Davies L, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry. 2006;63:1079–1087
  11. Lewis SW, Barnes TR, Davies L, et al. Randomized controlled trial of effect of prescription of clozapine vs other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull. 2006;32:715–723
  12. Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and chizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371:1085–1097

PII: S1357-3039(08)00149-7

doi: 10.1016/j.mpmed.2008.05.007

Medicine
Volume 36, Issue 8 , Pages 405-409 , August 2008

Article Tools